ID   C1QBP_HUMAN             Reviewed;         282 AA.
AC   Q07021; Q2HXR8; Q9NNY8;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1995, sequence version 1.
DT   18-JUN-2025, entry version 230.
DE   RecName: Full=Complement component 1 Q subcomponent-binding protein, mitochondrial;
DE   AltName: Full=ASF/SF2-associated protein p32;
DE   AltName: Full=Glycoprotein gC1qBP;
DE            Short=C1qBP;
DE   AltName: Full=Hyaluronan-binding protein 1;
DE   AltName: Full=Mitochondrial matrix protein p32;
DE   AltName: Full=gC1q-R protein;
DE   AltName: Full=p33;
DE            Short=SF2AP32 {ECO:0000303|PubMed:18191643};
DE   Flags: Precursor;
GN   Name=C1QBP; Synonyms=GC1QBP, HABP1, SF2P32;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 74; 76-93 AND 208-216.
RC   TISSUE=Fibroblast;
RX   PubMed=8262387; DOI=10.1016/0378-1119(93)90108-f;
RA   Honore B., Madsen P., Rasmussen H.H., Vandekerckhove J., Celis J.E.,
RA   Leffers H.;
RT   "Cloning and expression of a cDNA covering the complete coding region of
RT   the P32 subunit of human pre-mRNA splicing factor SF2.";
RL   Gene 134:283-287(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, FUNCTION, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=8195709; DOI=10.1084/jem.179.6.1809;
RA   Ghebrehiwet B., Lim B.L., Peerschke E.I., Willis A.C., Reid K.B.;
RT   "Isolation, cDNA cloning, and overexpression of a 33-kD cell surface
RT   glycoprotein that binds to the globular 'heads' of C1q.";
RL   J. Exp. Med. 179:1809-1821(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11278463; DOI=10.1074/jbc.m009064200;
RA   Tye A.J., Ghebrehiwet B., Guo N., Sastry K.N., Chow B.K.C.,
RA   Peerschke E.I.B., Lim B.L.;
RT   "The human gC1qR/p32 gene, C1qBP. Genomic organization and promoter
RT   analysis.";
RL   J. Biol. Chem. 276:17069-17075(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   SeattleSNPs variation discovery resource;
RL   Submitted (JAN-2006) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung, and Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 5-282, AND PROTEIN SEQUENCE OF 74-114.
RX   PubMed=1830244; DOI=10.1016/0092-8674(91)90627-b;
RA   Krainer A.R., Mayeda A., Kozak D., Binns G.;
RT   "Functional expression of cloned human splicing factor SF2: homology to
RT   RNA-binding proteins, U1 70K, and Drosophila splicing regulators.";
RL   Cell 66:383-394(1991).
RN   [8]
RP   PROTEIN SEQUENCE OF 74-88, FUNCTION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=8662673; DOI=10.1074/jbc.271.22.13040;
RA   Herwald H., Dedio J., Kellner R., Loos M., Muller-Esterl W.;
RT   "Isolation and characterization of the kininogen-binding protein p33 from
RT   endothelial cells. Identity with the gC1q receptor.";
RL   J. Biol. Chem. 271:13040-13047(1996).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 86-282.
RX   PubMed=8567680; DOI=10.1074/jbc.271.4.2206;
RA   Deb T.B., Datta K.;
RT   "Molecular cloning of human fibroblast hyaluronic acid-binding protein
RT   confirms its identity with P-32, a protein co-purified with splicing factor
RT   SF2. Hyaluronic acid-binding protein as P-32 protein, co-purified with
RT   splicing factor SF2.";
RL   J. Biol. Chem. 271:2206-2212(1996).
RN   [10]
RP   INTERACTION WITH VTN.
RX   PubMed=8900153; DOI=10.1074/jbc.271.43.26739;
RA   Lim B.L., Reid K.B., Ghebrehiwet B., Peerschke E.I., Leigh L.A.,
RA   Preissner K.T.;
RT   "The binding protein for globular heads of complement C1q, gC1qR.
RT   Functional expression and characterization as a novel vitronectin binding
RT   factor.";
RL   J. Biol. Chem. 271:26739-26744(1996).
RN   [11]
RP   FUNCTION.
RX   PubMed=8710908; DOI=10.1073/pnas.93.16.8552;
RA   Joseph K., Ghebrehiwet B., Peerschke E.I., Reid K.B., Kaplan A.P.;
RT   "Identification of the zinc-dependent endothelial cell binding protein for
RT   high molecular weight kininogen and factor XII: identity with the receptor
RT   that binds to the globular 'heads' of C1q (gC1q-R).";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:8552-8557(1996).
RN   [12]
RP   SUBCELLULAR LOCATION.
RX   PubMed=9191880; DOI=10.1006/clin.1997.4374;
RA   Peterson K.L., Zhang W., Lu P.D., Keilbaugh S.A., Peerschke E.I.,
RA   Ghebrehiwet B.;
RT   "The C1q-binding cell membrane proteins cC1q-R and gC1q-R are released from
RT   activated cells: subcellular distribution and immunochemical
RT   characterization.";
RL   Clin. Immunol. Immunopathol. 84:17-26(1997).
RN   [13]
RP   INTERACTION WITH EPSTEIN-BARR VIRUS EBNA1 (MICROBIAL INFECTION), AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=9299613; DOI=10.1006/viro.1997.8739;
RA   Wang Y., Finan J.E., Middeldorp J.M., Hayward S.D.;
RT   "P32/TAP, a cellular protein that interacts with EBNA-1 of Epstein-Barr
RT   virus.";
RL   Virology 236:18-29(1997).
RN   [14]
RP   SUBCELLULAR LOCATION.
RX   PubMed=9305894; DOI=10.1074/jbc.272.39.24363;
RA   Muta T., Kang D., Kitajima S., Fujiwara T., Hamasaki N.;
RT   "p32 protein, a splicing factor 2-associated protein, is localized in
RT   mitochondrial matrix and is functionally important in maintaining oxidative
RT   phosphorylation.";
RL   J. Biol. Chem. 272:24363-24370(1997).
RN   [15]
RP   INTERACTION WITH CD93, AND SUBCELLULAR LOCATION.
RX   PubMed=9233640;
RA   Ghebrehiwet B., Lu P.D., Zhang W., Keilbaugh S.A., Leigh L.E., Eggleton P.,
RA   Reid K.B., Peerschke E.I.;
RT   "Evidence that the two C1q binding membrane proteins, gC1q-R and cC1q-R,
RT   associate to form a complex.";
RL   J. Immunol. 159:1429-1436(1997).
RN   [16]
RP   FUNCTION.
RX   PubMed=9461517; DOI=10.1042/bj3300247;
RA   Leigh L.E., Ghebrehiwet B., Perera T.P., Bird I.N., Strong P., Kishore U.,
RA   Reid K.B., Eggleton P.;
RT   "C1q-mediated chemotaxis by human neutrophils: involvement of gClqR and G-
RT   protein signalling mechanisms.";
RL   Biochem. J. 330:247-254(1998).
RN   [17]
RP   FUNCTION.
RX   PubMed=10479529; DOI=10.1006/clim.1999.4753;
RA   Joseph K., Ghebrehiwet B., Kaplan A.P.;
RT   "Cytokeratin 1 and gC1qR mediate high molecular weight kininogen binding to
RT   endothelial cells.";
RL   Clin. Immunol. 92:246-255(1999).
RN   [18]
RP   FUNCTION, AND INTERACTION WITH SRSF1 AND SRSF9.
RX   PubMed=10022843; DOI=10.1093/emboj/18.4.1014;
RA   Petersen-Mahrt S.K., Estmer C., Ohrmalm C., Matthews D.A., Russell W.C.,
RA   Akusjarvi G.;
RT   "The splicing factor-associated protein, p32, regulates RNA splicing by
RT   inhibiting ASF/SF2 RNA binding and phosphorylation.";
RL   EMBO J. 18:1014-1024(1999).
RN   [19]
RP   FUNCTION (MICROBIAL INFECTION), INTERACTION WITH L.MONOCYTOGENES INLB
RP   (MICROBIAL INFECTION), AND SUBCELLULAR LOCATION.
RX   PubMed=10747014; DOI=10.1093/emboj/19.7.1458;
RA   Braun L., Ghebrehiwet B., Cossart P.;
RT   "gC1q-R/p32, a C1q-binding protein, is a receptor for the InlB invasion
RT   protein of Listeria monocytogenes.";
RL   EMBO J. 19:1458-1466(2000).
RN   [20]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH STAPHYLOCOCCUS AUREUS
RP   SPA.
RX   PubMed=10722602; DOI=10.1128/iai.68.4.2061-2068.2000;
RA   Nguyen T., Ghebrehiwet B., Peerschke E.I.;
RT   "Staphylococcus aureus protein A recognizes platelet gC1qR/p33: a novel
RT   mechanism for staphylococcal interactions with platelets.";
RL   Infect. Immun. 68:2061-2068(2000).
RN   [21]
RP   FUNCTION, AND INTERACTION WITH HCV CORE PROTEIN.
RX   PubMed=11086025; DOI=10.1172/jci10323;
RA   Kittlesen D.J., Chianese-Bullock K.A., Yao Z.Q., Braciale T.J., Hahn Y.S.;
RT   "Interaction between complement receptor gC1qR and hepatitis C virus core
RT   protein inhibits T-lymphocyte proliferation.";
RL   J. Clin. Invest. 106:1239-1249(2000).
RN   [22]
RP   INTERACTION WITH RUBELLA VIRUS CAPSID PROTEIN.
RX   PubMed=10823864; DOI=10.1128/jvi.74.12.5569-5576.2000;
RA   Beatch M.D., Hobman T.C.;
RT   "Rubella virus capsid associates with host cell protein p32 and localizes
RT   to mitochondria.";
RL   J. Virol. 74:5569-5576(2000).
RN   [23]
RP   SUBCELLULAR LOCATION.
RX   PubMed=11493647; DOI=10.1242/jcs.114.11.2115;
RA   van Leeuwen H.C., O'Hare P.;
RT   "Retargeting of the mitochondrial protein p32/gC1Qr to a cytoplasmic
RT   compartment and the cell surface.";
RL   J. Cell Sci. 114:2115-2123(2001).
RN   [24]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH L.MONOCYTOGENES INLB
RP   (MICROBIAL INFECTION).
RX   PubMed=12411480; DOI=10.1093/emboj/cdf558;
RA   Marino M., Banerjee M., Jonquieres R., Cossart P., Ghosh P.;
RT   "GW domains of the Listeria monocytogenes invasion protein InlB are SH3-
RT   like and mediate binding to host ligands.";
RL   EMBO J. 21:5623-5634(2002).
RN   [25]
RP   FUNCTION.
RX   PubMed=11859136; DOI=10.4049/jimmunol.168.5.2441;
RA   Feng X., Tonnesen M.G., Peerschke E.I., Ghebrehiwet B.;
RT   "Cooperation of C1q receptors and integrins in C1q-mediated endothelial
RT   cell adhesion and spreading.";
RL   J. Immunol. 168:2441-2448(2002).
RN   [26]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH RUBELLA VIRUS CAPSID
RP   PROTEIN.
RX   PubMed=12034482; DOI=10.1016/s0168-1702(02)00030-8;
RA   Mohan K.V., Ghebrehiwet B., Atreya C.D.;
RT   "The N-terminal conserved domain of rubella virus capsid interacts with the
RT   C-terminal region of cellular p32 and overexpression of p32 enhances the
RT   viral infectivity.";
RL   Virus Res. 85:151-161(2002).
RN   [27]
RP   FUNCTION (MICROBIAL INFECTION), AND MUTAGENESIS OF GLY-107.
RX   PubMed=12833064; DOI=10.1038/ncb1000;
RA   Zheng Y.H., Yu H.F., Peterlin B.M.;
RT   "Human p32 protein relieves a post-transcriptional block to HIV replication
RT   in murine cells.";
RL   Nat. Cell Biol. 5:611-618(2003).
RN   [28]
RP   ERRATUM OF PUBMED:12833064.
RA   Zheng Y.H., Yu H.F., Peterlin B.M.;
RL   Nat. Cell Biol. 5:839-839(2003).
RN   [29]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=12574814; DOI=10.1267/THRO03020331;
RA   Peerschke E.I., Murphy T.K., Ghebrehiwet B.;
RT   "Activation-dependent surface expression of gC1qR/p33 on human blood
RT   platelets.";
RL   Thromb. Haemost. 89:331-339(2003).
RN   [30]
RP   INTERACTION WITH HRK, AND SUBCELLULAR LOCATION.
RX   PubMed=15031724; DOI=10.1038/sj.cdd.4401418;
RA   Sunayama J., Ando Y., Itoh N., Tomiyama A., Sakurada K., Sugiyama A.,
RA   Kang D., Tashiro F., Gotoh Y., Kuchino Y., Kitanaka C.;
RT   "Physical and functional interaction between BH3-only protein Hrk and
RT   mitochondrial pore-forming protein p32.";
RL   Cell Death Differ. 11:771-781(2004).
RN   [31]
RP   FUNCTION, AND INTERACTION WITH NFYB.
RX   PubMed=15243141; DOI=10.1093/nar/gkh692;
RA   Chattopadhyay C., Hawke D., Kobayashi R., Maity S.N.;
RT   "Human p32, interacts with B subunit of the CCAAT-binding factor, CBF/NF-Y,
RT   and inhibits CBF-mediated transcription activation in vitro.";
RL   Nucleic Acids Res. 32:3632-3641(2004).
RN   [32]
RP   FUNCTION, AND INDUCTION.
RX   PubMed=16177118; DOI=10.4049/jimmunol.175.7.4706;
RA   Waggoner S.N., Cruise M.W., Kassel R., Hahn Y.S.;
RT   "gC1q receptor ligation selectively down-regulates human IL-12 production
RT   through activation of the phosphoinositide 3-kinase pathway.";
RL   J. Immunol. 175:4706-4714(2005).
RN   [33]
RP   ERRATUM OF PUBMED:16177118.
RA   Waggoner S.N., Cruise M.W., Kassel R., Hahn Y.S.;
RL   J. Immunol. 178:3332-3332(2007).
RN   [34]
RP   INTERACTION WITH CDK13.
RX   PubMed=16721827; DOI=10.1002/jcb.20986;
RA   Even Y., Durieux S., Escande M.L., Lozano J.C., Peaucellier G., Weil D.,
RA   Geneviere A.M.;
RT   "CDC2L5, a Cdk-like kinase with RS domain, interacts with the ASF/SF2-
RT   associated protein p32 and affects splicing in vivo.";
RL   J. Cell. Biochem. 99:890-904(2006).
RN   [35]
RP   INTERACTION WITH HIV-1 TAT.
RX   PubMed=16537587; DOI=10.1128/jvi.80.7.3189-3204.2006;
RA   Berro R., Kehn K., de la Fuente C., Pumfery A., Adair R., Wade J.,
RA   Colberg-Poley A.M., Hiscott J., Kashanchi F.;
RT   "Acetylated Tat regulates human immunodeficiency virus type 1 splicing
RT   through its interaction with the splicing regulator p32.";
RL   J. Virol. 80:3189-3204(2006).
RN   [36]
RP   FUNCTION.
RX   PubMed=16140380; DOI=10.1016/j.molimm.2005.07.030;
RA   Vegh Z., Kew R.R., Gruber B.L., Ghebrehiwet B.;
RT   "Chemotaxis of human monocyte-derived dendritic cells to complement
RT   component C1q is mediated by the receptors gC1qR and cC1qR.";
RL   Mol. Immunol. 43:1402-1407(2006).
RN   [37]
RP   FUNCTION.
RX   PubMed=17881511; DOI=10.1189/jlb.0507268;
RA   Waggoner S.N., Hall C.H., Hahn Y.S.;
RT   "HCV core protein interaction with gC1q receptor inhibits Th1
RT   differentiation of CD4+ T cells via suppression of dendritic cell IL-12
RT   production.";
RL   J. Leukoc. Biol. 82:1407-1419(2007).
RN   [38]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-188, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17693683; DOI=10.1074/mcp.m700120-mcp200;
RA   Tang L.-Y., Deng N., Wang L.-S., Dai J., Wang Z.-L., Jiang X.-S., Li S.-J.,
RA   Li L., Sheng Q.-H., Wu D.-Q., Li L., Zeng R.;
RT   "Quantitative phosphoproteome profiling of Wnt3a-mediated signaling
RT   network: indicating the involvement of ribonucleoside-diphosphate reductase
RT   M2 subunit phosphorylation at residue serine 20 in canonical Wnt signal
RT   transduction.";
RL   Mol. Cell. Proteomics 6:1952-1967(2007).
RN   [39]
RP   INTERACTION WITH CDKN2A, AND SUBCELLULAR LOCATION.
RX   PubMed=17486078; DOI=10.1038/sj.onc.1210485;
RA   Reef S., Shifman O., Oren M., Kimchi A.;
RT   "The autophagic inducer smARF interacts with and is stabilized by the
RT   mitochondrial p32 protein.";
RL   Oncogene 26:6677-6683(2007).
RN   [40]
RP   INTERACTION WITH PLEKHN1.
RX   PubMed=18191643; DOI=10.1016/j.bbamcr.2007.12.009;
RA   Sano E., Shono S., Tashiro K., Konishi H., Yamauchi E., Taniguchi H.;
RT   "Novel tyrosine phosphorylated and cardiolipin-binding protein CLPABP
RT   functions as mitochondrial RNA granule.";
RL   Biochim. Biophys. Acta 1783:1036-1047(2008).
RN   [41]
RP   FUNCTION, INTERACTION WITH FOXC1, AND SUBCELLULAR LOCATION.
RX   PubMed=18676636; DOI=10.1167/iovs.07-1625;
RA   Huang L., Chi J., Berry F.B., Footz T.K., Sharp M.W., Walter M.A.;
RT   "Human p32 is a novel FOXC1-interacting protein that regulates FOXC1
RT   transcriptional activity in ocular cells.";
RL   Invest. Ophthalmol. Vis. Sci. 49:5243-5249(2008).
RN   [42]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-201, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [43]
RP   FUNCTION.
RX   PubMed=19004836; DOI=10.1074/jbc.m804246200;
RA   Yadav G., Prasad R.L., Jha B.K., Rai V., Bhakuni V., Datta K.;
RT   "Evidence for inhibitory interaction of hyaluronan-binding protein 1
RT   (HABP1/p32/gC1qR) with Streptococcus pneumoniae hyaluronidase.";
RL   J. Biol. Chem. 284:3897-3905(2009).
RN   [44]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH MAVS.
RX   PubMed=19164550; DOI=10.1073/pnas.0811029106;
RA   Xu L., Xiao N., Liu F., Ren H., Gu J.;
RT   "Inhibition of RIG-I and MDA5-dependent antiviral response by gC1qR at
RT   mitochondria.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:1530-1535(2009).
RN   [45]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-188, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [46]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-91, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [47]
RP   FUNCTION.
RX   PubMed=20810993; DOI=10.4049/jimmunol.0903215;
RA   Agostinis C., Bulla R., Tripodo C., Gismondi A., Stabile H., Bossi F.,
RA   Guarnotta C., Garlanda C., De Seta F., Spessotto P., Santoni A.,
RA   Ghebrehiwet B., Girardi G., Tedesco F.;
RT   "An alternative role of C1q in cell migration and tissue remodeling:
RT   contribution to trophoblast invasion and placental development.";
RL   J. Immunol. 185:4420-4429(2010).
RN   [48]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [49]
RP   INTERACTION WITH PPIF.
RX   PubMed=20950273; DOI=10.1042/bj20101431;
RA   McGee A.M., Baines C.P.;
RT   "Complement 1q-binding protein inhibits the mitochondrial permeability
RT   transition pore and protects against oxidative stress-induced death.";
RL   Biochem. J. 433:119-125(2011).
RN   [50]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH FBL; RRP1; DDX21;
RP   DDX50 AND NCL.
RX   PubMed=21536856; DOI=10.1074/mcp.m110.006148;
RA   Yoshikawa H., Komatsu W., Hayano T., Miura Y., Homma K., Izumikawa K.,
RA   Ishikawa H., Miyazawa N., Tachikawa H., Yamauchi Y., Isobe T.,
RA   Takahashi N.;
RT   "Splicing factor 2-associated protein p32 participates in ribosome
RT   biogenesis by regulating the binding of Nop52 and fibrillarin to
RT   preribosome particles.";
RL   Mol. Cell. Proteomics 10:0-0(2011).
RN   [51]
RP   FUNCTION, AND INTERACTION WITH KRT1.
RX   PubMed=21544310; DOI=10.1160/th10-09-0591;
RA   Pixley R.A., Espinola R.G., Ghebrehiwet B., Joseph K., Kao A., Bdeir K.,
RA   Cines D.B., Colman R.W.;
RT   "Interaction of high-molecular-weight kininogen with endothelial cell
RT   binding proteins suPAR, gC1qR and cytokeratin 1 determined by surface
RT   plasmon resonance (BiaCore).";
RL   Thromb. Haemost. 105:1053-1059(2011).
RN   [52]
RP   FUNCTION, AND INTERACTION WITH CD209.
RX   PubMed=22700724; DOI=10.1182/blood-2011-07-369728;
RA   Hosszu K.K., Valentino A., Vinayagasundaram U., Vinayagasundaram R.,
RA   Joyce M.G., Ji Y., Peerschke E.I., Ghebrehiwet B.;
RT   "DC-SIGN, C1q, and gC1qR form a trimolecular receptor complex on the
RT   surface of monocyte-derived immature dendritic cells.";
RL   Blood 120:1228-1236(2012).
RN   [53]
RP   INTERACTION WITH RUBELLA VIRUS PROTEASE/METHYLTRANSFERASE P150.
RX   PubMed=22238231; DOI=10.1099/vir.0.038901-0;
RA   Suppiah S., Mousa H.A., Tzeng W.P., Matthews J.D., Frey T.K.;
RT   "Binding of cellular p32 protein to the rubella virus P150 replicase
RT   protein via PxxPxR motifs.";
RL   J. Gen. Virol. 93:807-816(2012).
RN   [54]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-87, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [55]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-205 AND THR-214, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [56]
RP   CLEAVAGE OF TRANSIT PEPTIDE [LARGE SCALE ANALYSIS] AFTER SER-73, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [57]
RP   INTERACTION WITH POLGARF, SUBCELLULAR LOCATION, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=32958672; DOI=10.1073/pnas.2001433117;
RA   Loughran G., Zhdanov A.V., Mikhaylova M.S., Rozov F.N., Datskevich P.N.,
RA   Kovalchuk S.I., Serebryakova M.V., Kiniry S.J., Michel A.M.,
RA   O'Connor P.B.F., Papkovsky D.B., Atkins J.F., Baranov P.V., Shatsky I.N.,
RA   Andreev D.E.;
RT   "Unusually efficient CUG initiation of an overlapping reading frame in POLG
RT   mRNA yields novel protein POLGARF.";
RL   Proc. Natl. Acad. Sci. U.S.A. 117:24936-24946(2020).
RN   [58]
RP   FUNCTION, INVOLVEMENT IN COXPD33, AND VARIANTS COXPD33 SER-186; TYR-188
RP   DEL; LEU-204; TRP-247; PHE-275 AND PRO-275.
RX   PubMed=28942965; DOI=10.1016/j.ajhg.2017.08.015;
RA   Feichtinger R.G., Olahova M., Kishita Y., Garone C., Kremer L.S., Yagi M.,
RA   Uchiumi T., Jourdain A.A., Thompson K., D'Souza A.R., Kopajtich R.,
RA   Alston C.L., Koch J., Sperl W., Mastantuono E., Strom T.M., Wortmann S.B.,
RA   Meitinger T., Pierre G., Chinnery P.F., Chrzanowska-Lightowlers Z.M.,
RA   Lightowlers R.N., DiMauro S., Calvo S.E., Mootha V.K., Moggio M.,
RA   Sciacco M., Comi G.P., Ronchi D., Murayama K., Ohtake A.,
RA   Rebelo-Guiomar P., Kohda M., Kang D., Mayr J.A., Taylor R.W., Okazaki Y.,
RA   Minczuk M., Prokisch H.;
RT   "Biallelic C1QBP mutations cause severe neonatal-, childhood-, or later-
RT   onset cardiomyopathy associated with combined respiratory-chain
RT   deficiencies.";
RL   Am. J. Hum. Genet. 101:525-538(2017).
RN   [59]
RP   FUNCTION, AND INTERACTION WITH MRE11 AND RAD50.
RX   PubMed=31353207; DOI=10.1016/j.molcel.2019.06.023;
RA   Bai Y., Wang W., Li S., Zhan J., Li H., Zhao M., Zhou X.A., Li S., Li X.,
RA   Huo Y., Shen Q., Zhou M., Zhang H., Luo J., Sung P., Zhu W.G., Xu X.,
RA   Wang J.;
RT   "C1QBP promotes homologous recombination by stabilizing MRE11 and
RT   controlling the assembly and activation of MRE11/RAD50/NBS1 complex.";
RL   Mol. Cell 75:1299-1314(2019).
RN   [60]
RP   FUNCTION.
RX   PubMed=39019044; DOI=10.1016/j.molcel.2024.06.023;
RA   Kim S., Tan S., Ku J., Widowati T.A., Ku D., Lee K., You K., Kim Y.;
RT   "RNA 5-methylcytosine marks mitochondrial double-stranded RNAs for
RT   degradation and cytosolic release.";
RL   Mol. Cell 84:2935-2948(2024).
RN   [61]
RP   X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS).
RX   PubMed=10097078; DOI=10.1073/pnas.96.7.3572;
RA   Jiang J., Zhang Y., Krainer A.R., Xu R.-M.;
RT   "Crystal structure of human p32, a doughnut-shaped acidic mitochondrial
RT   matrix protein.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:3572-3577(1999).
CC   -!- FUNCTION: Multifunctional and multicompartmental protein involved in
CC       inflammation and infection processes, ribosome biogenesis, protein
CC       synthesis in mitochondria, regulation of apoptosis, transcriptional
CC       regulation and pre-mRNA splicing (PubMed:10022843, PubMed:10479529,
CC       PubMed:10722602, PubMed:11086025, PubMed:11859136, PubMed:15243141,
CC       PubMed:16140380, PubMed:16177118, PubMed:17881511, PubMed:18676636,
CC       PubMed:19004836, PubMed:19164550, PubMed:20810993, PubMed:21536856,
CC       PubMed:21544310, PubMed:22700724, PubMed:28942965, PubMed:8662673,
CC       PubMed:8710908, PubMed:9461517). At the cell surface is thought to act
CC       as an endothelial receptor for plasma proteins of the complement and
CC       kallikrein-kinin cascades (PubMed:10479529, PubMed:11859136,
CC       PubMed:8662673, PubMed:8710908). Putative receptor for C1q;
CC       specifically binds to the globular 'heads' of C1q thus inhibiting C1;
CC       may perform the receptor function through a complex with C1qR/CD93
CC       (PubMed:20810993, PubMed:8195709). In complex with cytokeratin-1/KRT1
CC       is a high affinity receptor for kininogen-1/HMWK (PubMed:21544310). Can
CC       also bind other plasma proteins, such as coagulation factor XII leading
CC       to its autoactivation. May function to bind initially fluid kininogen-1
CC       to the cell membrane. The secreted form may enhance both extrinsic and
CC       intrinsic coagulation pathways. It is postulated that the cell surface
CC       form requires docking with transmembrane proteins for downstream
CC       signaling which might be specific for a cell-type or response. By
CC       acting as C1q receptor is involved in chemotaxis of immature dendritic
CC       cells and neutrophils and is proposed to signal through CD209/DC-SIGN
CC       on immature dendritic cells, through integrin alpha-4/beta-1 during
CC       trophoblast invasion of the decidua, and through integrin beta-1 during
CC       endothelial cell adhesion and spreading (PubMed:16140380,
CC       PubMed:22700724, PubMed:9461517). Signaling involved in inhibition of
CC       innate immune response is implicating the PI3K-AKT/PKB pathway
CC       (PubMed:16177118). Required for protein synthesis in mitochondria
CC       (PubMed:28942965). In mitochondrial translation may be involved in
CC       formation of functional 55S mitoribosomes; the function seems to
CC       involve its RNA-binding activity (By similarity). Acts as a RNA
CC       modification reader, which specifically recognizes and binds
CC       mitochondrial RNAs modified by C5-methylcytosine (m5C) in response to
CC       stress, and promotes recruitment of the mitochondrial degradosome
CC       complex, leading to their degradation (PubMed:39019044). May be
CC       involved in the nucleolar ribosome maturation process; the function may
CC       involve the exchange of FBL for RRP1 in the association with pre-
CC       ribosome particles (By similarity). Involved in regulation of RNA
CC       splicing by inhibiting the RNA-binding capacity of SRSF1 and its
CC       phosphorylation (PubMed:10022843, PubMed:21536856). Is required for the
CC       nuclear translocation of splicing factor U2AF1L4 (By similarity).
CC       Involved in regulation of CDKN2A- and HRK-mediated apoptosis.
CC       Stabilizes mitochondrial CDKN2A isoform smARF (PubMed:17486078). May be
CC       involved in regulation of FOXC1 transcriptional activity and NFY/CCAAT-
CC       binding factor complex-mediated transcription (PubMed:15243141,
CC       PubMed:18676636). May play a role in antibacterial defense as it can
CC       bind to cell surface hyaluronan and inhibit Streptococcus pneumoniae
CC       hyaluronate lyase (PubMed:19004836). May be involved in modulation of
CC       the immune response; ligation by HCV core protein is resulting in
CC       suppression of interleukin-12 production in monocyte-derived dendritic
CC       cells (PubMed:11086025, PubMed:17881511). Involved in regulation of
CC       antiviral response by inhibiting RIGI- and IFIH1-mediated signaling
CC       pathways probably involving its association with MAVS after viral
CC       infection (PubMed:19164550). Acts as a regulator of DNA repair via
CC       homologous recombination by inhibiting the activity of MRE11: interacts
CC       with unphosphorylated MRE11 and RAD50 in absence of DNA damage,
CC       preventing formation and activity of the MRN complex. Following DNA
CC       damage, dissociates from phosphorylated MRE11, allowing formation of
CC       the MRN complex (PubMed:31353207). {ECO:0000250|UniProtKB:O35658,
CC       ECO:0000269|PubMed:10022843, ECO:0000269|PubMed:10479529,
CC       ECO:0000269|PubMed:10722602, ECO:0000269|PubMed:11086025,
CC       ECO:0000269|PubMed:11859136, ECO:0000269|PubMed:15243141,
CC       ECO:0000269|PubMed:16140380, ECO:0000269|PubMed:16177118,
CC       ECO:0000269|PubMed:17486078, ECO:0000269|PubMed:17881511,
CC       ECO:0000269|PubMed:18676636, ECO:0000269|PubMed:19004836,
CC       ECO:0000269|PubMed:19164550, ECO:0000269|PubMed:20810993,
CC       ECO:0000269|PubMed:21536856, ECO:0000269|PubMed:21544310,
CC       ECO:0000269|PubMed:22700724, ECO:0000269|PubMed:28942965,
CC       ECO:0000269|PubMed:31353207, ECO:0000269|PubMed:39019044,
CC       ECO:0000269|PubMed:8195709, ECO:0000269|PubMed:8662673,
CC       ECO:0000269|PubMed:8710908, ECO:0000269|PubMed:9461517}.
CC   -!- FUNCTION: (Microbial infection) Involved in HIV-1 replication,
CC       presumably by contributing to splicing of viral RNA.
CC       {ECO:0000269|PubMed:12833064}.
CC   -!- FUNCTION: (Microbial infection) In infection processes acts as an
CC       attachment site for microbial proteins, including Listeria
CC       monocytogenes internalin B (InlB) and Staphylococcus aureus protein A.
CC       {ECO:0000269|PubMed:10722602, ECO:0000269|PubMed:10747014,
CC       ECO:0000269|PubMed:12411480}.
CC   -!- FUNCTION: (Microbial infection) Involved in replication of Rubella
CC       virus. {ECO:0000269|PubMed:12034482}.
CC   -!- SUBUNIT: Homotrimer; three monomers form a donut-shaped structure with
CC       an unusually asymmetric charge distribution on the surface. Interacts
CC       with CDK13, HRK, VTN, NFYB, ADRA1B, FOXC1, DDX21, DDX50, NCL, SRSF1,
CC       SRSF9 and CDKN2A isoform smARF. Interacts with CD93; the association
CC       may represent a cell surface C1q receptor. Interacts with KRT1; the
CC       association represents a cell surface kininogen receptor. Interacts
CC       with CD209; the interaction is indicative for a C1q:C1QBP:CD209
CC       signaling complex. Interacts with FBL and RRP1; the respective
CC       interactions with C1QBP are competitive. Probably associates with the
CC       mitoribosome. Interacts with MAVS; the interaction occurs upon viral
CC       transfection. Interacts with PPIF. Interacts with U2AF1L4. Interacts
CC       with PLEKHN1 (PubMed:18191643). Interacts with VGF-derived peptide
CC       TLQP-21 (By similarity). Interacts with POLGARF which is produced from
CC       an alternative reading frame of the POLG gene; the interaction results
CC       in nucleolar localization of C1QBP, probably due to prevention of C1QBP
CC       maturation and redirection from mitochondria to nucleoli
CC       (PubMed:32958672). Interacts with MRE11 and RAD50; forming the MRC
CC       (MRE11-RAD50-C1QBP) complex that inhibits the activity of MRE11
CC       (PubMed:31353207). {ECO:0000250|UniProtKB:O35658,
CC       ECO:0000250|UniProtKB:O35796, ECO:0000269|PubMed:10022843,
CC       ECO:0000269|PubMed:11086025, ECO:0000269|PubMed:15031724,
CC       ECO:0000269|PubMed:15243141, ECO:0000269|PubMed:16721827,
CC       ECO:0000269|PubMed:17486078, ECO:0000269|PubMed:18191643,
CC       ECO:0000269|PubMed:18676636, ECO:0000269|PubMed:19164550,
CC       ECO:0000269|PubMed:20950273, ECO:0000269|PubMed:21536856,
CC       ECO:0000269|PubMed:21544310, ECO:0000269|PubMed:22700724,
CC       ECO:0000269|PubMed:31353207, ECO:0000269|PubMed:32958672,
CC       ECO:0000269|PubMed:8900153, ECO:0000269|PubMed:9233640}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with Rubella virus capsid
CC       protein; the interaction occurs in mitochondria (PubMed:10823864,
CC       PubMed:12034482). Interacts with Rubella virus
CC       protease/methyltransferase p150 (PubMed:22238231).
CC       {ECO:0000269|PubMed:10823864, ECO:0000269|PubMed:12034482,
CC       ECO:0000269|PubMed:22238231}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with Staphylococcus aureus
CC       protein A/spa. {ECO:0000269|PubMed:10722602}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with Staphylococcus aureus
CC       protein A/spa, HIV-1 Tat and HCV core protein.
CC       {ECO:0000269|PubMed:10722602}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with HIV-1 Tat and HCV core
CC       protein. {ECO:0000269|PubMed:16537587}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with L.monocytogenes
CC       internalin B. {ECO:0000269|PubMed:10747014,
CC       ECO:0000269|PubMed:12411480}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with Epstein-Barr virus EBNA1.
CC       {ECO:0000269|PubMed:9299613}.
CC   -!- INTERACTION:
CC       Q07021; P02647: APOA1; NbExp=2; IntAct=EBI-347528, EBI-701692;
CC       Q07021; Q14004-2: CDK13; NbExp=6; IntAct=EBI-347528, EBI-6375898;
CC       Q07021; Q8N726: CDKN2A; NbExp=3; IntAct=EBI-347528, EBI-625922;
CC       Q07021; Q6RFH8: DUX4L9; NbExp=3; IntAct=EBI-347528, EBI-11599882;
CC       Q07021; P00748: F12; NbExp=2; IntAct=EBI-347528, EBI-6378830;
CC       Q07021; Q12948: FOXC1; NbExp=6; IntAct=EBI-347528, EBI-1175253;
CC       Q07021; O00198: HRK; NbExp=7; IntAct=EBI-347528, EBI-701322;
CC       Q07021; Q13351: KLF1; NbExp=3; IntAct=EBI-347528, EBI-8284732;
CC       Q07021; P01042: KNG1; NbExp=4; IntAct=EBI-347528, EBI-6378713;
CC       Q07021; Q14739: LBR; NbExp=2; IntAct=EBI-347528, EBI-1055147;
CC       Q07021; Q7Z434: MAVS; NbExp=5; IntAct=EBI-347528, EBI-995373;
CC       Q07021; Q05513: PRKCZ; NbExp=4; IntAct=EBI-347528, EBI-295351;
CC       Q07021; Q15139: PRKD1; NbExp=9; IntAct=EBI-347528, EBI-1181072;
CC       Q07021; Q8N3Z0: PRSS35; NbExp=4; IntAct=EBI-347528, EBI-20628340;
CC       Q07021; P04004: VTN; NbExp=10; IntAct=EBI-347528, EBI-1036653;
CC       Q07021; P67809: YBX1; NbExp=13; IntAct=EBI-347528, EBI-354065;
CC       Q07021; Q64364: Cdkn2a; Xeno; NbExp=4; IntAct=EBI-347528, EBI-1202287;
CC       Q07021; PRO_0000240177 [O40955]; Xeno; NbExp=2; IntAct=EBI-347528, EBI-6383633;
CC       Q07021; PRO_0000041308 [P07566]; Xeno; NbExp=3; IntAct=EBI-347528, EBI-6377932;
CC       Q07021; PRO_0000041302 [P08563]; Xeno; NbExp=3; IntAct=EBI-347528, EBI-11478341;
CC       Q07021; PRO_0000037566 [P27958]; Xeno; NbExp=4; IntAct=EBI-347528, EBI-6377335;
CC       PRO_0000018590; P02745: C1QA; NbExp=6; IntAct=EBI-14032968, EBI-1220209;
CC       PRO_0000018590; P02746: C1QB; NbExp=4; IntAct=EBI-14032968, EBI-2813376;
CC       PRO_0000018590; P02747: C1QC; NbExp=4; IntAct=EBI-14032968, EBI-1220222;
CC       PRO_0000018590; P0DTC4: E; Xeno; NbExp=2; IntAct=EBI-14032968, EBI-25475850;
CC       PRO_0000018590; P0DTC2: S; Xeno; NbExp=2; IntAct=EBI-14032968, EBI-25474821;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix
CC       {ECO:0000269|PubMed:15031724, ECO:0000269|PubMed:17486078,
CC       ECO:0000269|PubMed:19164550, ECO:0000269|PubMed:9305894}. Nucleus
CC       {ECO:0000269|PubMed:18676636, ECO:0000269|PubMed:9299613}. Nucleus,
CC       nucleolus {ECO:0000269|PubMed:21536856, ECO:0000269|PubMed:32958672}.
CC       Cell membrane {ECO:0000269|PubMed:10747014,
CC       ECO:0000269|PubMed:11493647, ECO:0000269|PubMed:12574814,
CC       ECO:0000269|PubMed:8195709, ECO:0000269|PubMed:8662673,
CC       ECO:0000269|PubMed:9191880, ECO:0000269|PubMed:9233640}; Peripheral
CC       membrane protein {ECO:0000269|PubMed:12574814,
CC       ECO:0000269|PubMed:8662673, ECO:0000269|PubMed:9191880}; Extracellular
CC       side. Secreted. Cytoplasm {ECO:0000269|PubMed:11493647,
CC       ECO:0000269|PubMed:9299613}. Note=Seems to be predominantly localized
CC       to mitochondria. Secreted by activated lymphocytes. Localizes to the
CC       nucleolus when coexpressed with POLGARF (PubMed:32958672). Interaction
CC       with POLGARF is likely to result in prevention of C1QBP maturation and
CC       redirection from mitochondria to nucleoli (PubMed:32958672).
CC       {ECO:0000269|PubMed:32958672}.
CC   -!- TISSUE SPECIFICITY: Expressed on cell surface of peripheral blood cells
CC       (at protein level); Surface expression is reported for macrophages and
CC       monocyte-derived dendritic cells. {ECO:0000269|PubMed:12574814,
CC       ECO:0000269|PubMed:8662673}.
CC   -!- INDUCTION: Enhanced cell surface expression upon platelet and monocyte
CC       activation. {ECO:0000269|PubMed:12574814, ECO:0000269|PubMed:16177118}.
CC   -!- DISEASE: Combined oxidative phosphorylation deficiency 33 (COXPD33)
CC       [MIM:617713]: An autosomal recessive disorder caused by multiple
CC       mitochondrial respiratory chain defects and impaired mitochondrial
CC       energy metabolism. Clinical manifestations are highly variable.
CC       Affected infants present with cardiomyopathy accompanied by
CC       multisystemic features involving liver, kidney, and brain. Death in
CC       infancy is observed in some patients. Children and adults present with
CC       myopathy and progressive external ophthalmoplegia.
CC       {ECO:0000269|PubMed:28942965}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the MAM33 family. {ECO:0000305}.
CC   -!- CAUTION: The subcellular location has been matter of debate. After
CC       being reported to be exclusively localized to mitochondria,
CC       demonstrations of promiscuous associations and locations were
CC       considered as artifactual due to the extremely acidic character and the
CC       use of different tagged versions of the protein (PubMed:11493647,
CC       PubMed:9305894). However, its location to multiple compartments linked
CC       to diverse functions is now accepted. The N-termini of the surface and
CC       secreted forms are identical to the reported processed mitochondrial
CC       form. {ECO:0000305|PubMed:11493647, ECO:0000305|PubMed:9305894}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L04636; AAA16315.1; -; mRNA.
DR   EMBL; X75913; CAA53512.1; -; mRNA.
DR   EMBL; AF338439; AAK26580.1; -; Genomic_DNA.
DR   EMBL; BT019898; AAV38701.1; -; mRNA.
DR   EMBL; BT019899; AAV38702.1; -; mRNA.
DR   EMBL; DQ372108; ABC79624.1; -; Genomic_DNA.
DR   EMBL; BC000435; AAH00435.1; -; mRNA.
DR   EMBL; BC013731; AAH13731.1; -; mRNA.
DR   EMBL; M69039; AAA73055.1; -; mRNA.
DR   EMBL; AF275902; AAF78763.1; -; mRNA.
DR   CCDS; CCDS11071.1; -.
DR   PIR; JT0762; JT0762.
DR   RefSeq; NP_001203.1; NM_001212.4.
DR   PDB; 1P32; X-ray; 2.25 A; A/B/C=74-282.
DR   PDB; 3RPX; X-ray; 2.65 A; A/B/C=96-282.
DR   PDB; 6SZW; X-ray; 3.14 A; A/B/C=74-282.
DR   PDB; 7TE3; X-ray; 2.20 A; A=75-282.
DR   PDBsum; 1P32; -.
DR   PDBsum; 3RPX; -.
DR   PDBsum; 6SZW; -.
DR   PDBsum; 7TE3; -.
DR   AlphaFoldDB; Q07021; -.
DR   SMR; Q07021; -.
DR   BioGRID; 107169; 855.
DR   CORUM; Q07021; -.
DR   DIP; DIP-31164N; -.
DR   FunCoup; Q07021; 2945.
DR   IntAct; Q07021; 352.
DR   MINT; Q07021; -.
DR   STRING; 9606.ENSP00000225698; -.
DR   DrugBank; DB09130; Copper.
DR   DrugBank; DB08818; Hyaluronic acid.
DR   TCDB; 9.B.103.1.1; the putative ca(2+) uniporter (gc1qr) family.
DR   GlyGen; Q07021; 2 sites, 1 N-linked glycan (1 site), 1 O-linked glycan (1 site).
DR   iPTMnet; Q07021; -.
DR   PhosphoSitePlus; Q07021; -.
DR   SwissPalm; Q07021; -.
DR   BioMuta; C1QBP; -.
DR   DMDM; 730772; -.
DR   OGP; Q07021; -.
DR   CPTAC; CPTAC-176; -.
DR   jPOST; Q07021; -.
DR   MassIVE; Q07021; -.
DR   PaxDb; 9606-ENSP00000225698; -.
DR   PeptideAtlas; Q07021; -.
DR   ProteomicsDB; 58500; -.
DR   Pumba; Q07021; -.
DR   TopDownProteomics; Q07021; -.
DR   Antibodypedia; 11562; 574 antibodies from 38 providers.
DR   DNASU; 708; -.
DR   Ensembl; ENST00000225698.8; ENSP00000225698.4; ENSG00000108561.8.
DR   GeneID; 708; -.
DR   KEGG; hsa:708; -.
DR   MANE-Select; ENST00000225698.8; ENSP00000225698.4; NM_001212.4; NP_001203.1.
DR   UCSC; uc002gby.2; human.
DR   AGR; HGNC:1243; -.
DR   CTD; 708; -.
DR   DisGeNET; 708; -.
DR   GeneCards; C1QBP; -.
DR   HGNC; HGNC:1243; C1QBP.
DR   HPA; ENSG00000108561; Low tissue specificity.
DR   MalaCards; C1QBP; -.
DR   MIM; 601269; gene.
DR   MIM; 617713; phenotype.
DR   OpenTargets; ENSG00000108561; -.
DR   VEuPathDB; HostDB:ENSG00000108561; -.
DR   eggNOG; KOG4024; Eukaryota.
DR   GeneTree; ENSGT00390000018406; -.
DR   InParanoid; Q07021; -.
DR   OMA; YEHTAYV; -.
DR   OrthoDB; 278212at2759; -.
DR   PAN-GO; Q07021; 9 GO annotations based on evolutionary models.
DR   PhylomeDB; Q07021; -.
DR   PathwayCommons; Q07021; -.
DR   Reactome; R-HSA-111471; Apoptotic factor-mediated response.
DR   Reactome; R-HSA-140837; Intrinsic Pathway of Fibrin Clot Formation.
DR   Reactome; R-HSA-8980692; RHOA GTPase cycle.
DR   Reactome; R-HSA-9013106; RHOC GTPase cycle.
DR   Reactome; R-HSA-9645722; Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function.
DR   SignaLink; Q07021; -.
DR   SIGNOR; Q07021; -.
DR   BioGRID-ORCS; 708; 240 hits in 1161 CRISPR screens.
DR   CD-CODE; 232F8A39; P-body.
DR   CD-CODE; FB4E32DD; Presynaptic clusters and postsynaptic densities.
DR   ChiTaRS; C1QBP; human.
DR   EvolutionaryTrace; Q07021; -.
DR   GeneWiki; C1QBP; -.
DR   GenomeRNAi; 708; -.
DR   Pharos; Q07021; Tbio.
DR   PRO; PR:Q07021; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q07021; protein.
DR   Bgee; ENSG00000108561; Expressed in mucosa of transverse colon and 205 other cell types or tissues.
DR   ExpressionAtlas; Q07021; baseline and differential.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IEA:Ensembl.
DR   GO; GO:0098982; C:GABA-ergic synapse; IEA:Ensembl.
DR   GO; GO:0098978; C:glutamatergic synapse; IEA:Ensembl.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005759; C:mitochondrial matrix; IDA:FlyBase.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0048786; C:presynaptic active zone; IEA:Ensembl.
DR   GO; GO:0031690; F:adrenergic receptor binding; ISS:UniProtKB.
DR   GO; GO:0062153; F:C5-methylcytidine-containing RNA reader activity; IDA:FlyBase.
DR   GO; GO:0001849; F:complement component C1q complex binding; IDA:UniProtKB.
DR   GO; GO:0060703; F:deoxyribonuclease inhibitor activity; IDA:UniProt.
DR   GO; GO:0004857; F:enzyme inhibitor activity; IDA:UniProtKB.
DR   GO; GO:0005540; F:hyaluronic acid binding; IDA:UniProtKB.
DR   GO; GO:0030984; F:kininogen binding; IDA:UniProtKB.
DR   GO; GO:0097177; F:mitochondrial ribosome binding; ISS:UniProtKB.
DR   GO; GO:0003729; F:mRNA binding; ISS:UniProtKB.
DR   GO; GO:0005080; F:protein kinase C binding; IEA:Ensembl.
DR   GO; GO:0003714; F:transcription corepressor activity; IDA:UniProtKB.
DR   GO; GO:0008134; F:transcription factor binding; IDA:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0006958; P:complement activation, classical pathway; IEA:UniProtKB-KW.
DR   GO; GO:0042256; P:cytosolic ribosome assembly; IMP:UniProtKB.
DR   GO; GO:0006974; P:DNA damage response; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; TAS:ProtInc.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0000957; P:mitochondrial RNA catabolic process; IDA:FlyBase.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0050687; P:negative regulation of defense response to virus; IMP:UniProtKB.
DR   GO; GO:2000042; P:negative regulation of double-strand break repair via homologous recombination; IDA:UniProtKB.
DR   GO; GO:0032695; P:negative regulation of interleukin-12 production; IDA:UniProtKB.
DR   GO; GO:0039534; P:negative regulation of MDA-5 signaling pathway; IDA:UniProtKB.
DR   GO; GO:0048025; P:negative regulation of mRNA splicing, via spliceosome; IDA:UniProtKB.
DR   GO; GO:0039536; P:negative regulation of RIG-I signaling pathway; IDA:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0032689; P:negative regulation of type II interferon production; IDA:UniProtKB.
DR   GO; GO:0043491; P:phosphatidylinositol 3-kinase/protein kinase B signal transduction; IMP:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:0045785; P:positive regulation of cell adhesion; IMP:UniProtKB.
DR   GO; GO:2000510; P:positive regulation of dendritic cell chemotaxis; IMP:UniProtKB.
DR   GO; GO:0070131; P:positive regulation of mitochondrial translation; ISS:UniProtKB.
DR   GO; GO:0090023; P:positive regulation of neutrophil chemotaxis; IDA:UniProtKB.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; IMP:UniProtKB.
DR   GO; GO:1900026; P:positive regulation of substrate adhesion-dependent cell spreading; IMP:UniProtKB.
DR   GO; GO:1901165; P:positive regulation of trophoblast cell migration; IMP:UniProtKB.
DR   GO; GO:0030449; P:regulation of complement activation; IDA:UniProtKB.
DR   GO; GO:0008380; P:RNA splicing; IEA:UniProtKB-KW.
DR   FunFam; 3.10.280.10:FF:000001; Complement component 1 Q subcomponent-binding protein, mitochondrial; 1.
DR   Gene3D; 3.10.280.10; Mitochondrial glycoprotein; 1.
DR   InterPro; IPR003428; MAM33.
DR   InterPro; IPR036561; MAM33_sf.
DR   PANTHER; PTHR10826; COMPLEMENT COMPONENT 1; 1.
DR   PANTHER; PTHR10826:SF1; COMPLEMENT COMPONENT 1 Q SUBCOMPONENT-BINDING PROTEIN, MITOCHONDRIAL; 1.
DR   Pfam; PF02330; MAM33; 1.
DR   SUPFAM; SSF54529; Mitochondrial glycoprotein MAM33-like; 1.
DR   neXtProt; NX_Q07021; -.
DR   PharmGKB; PA25624; -.
DR   TreeFam; TF315160; -.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Adaptive immunity; Apoptosis; Cell membrane;
KW   Complement pathway; Cytoplasm; Direct protein sequencing; Disease variant;
KW   DNA damage; Host-virus interaction; Immunity; Innate immunity; Membrane;
KW   Mitochondrion; mRNA processing; mRNA splicing; Nucleus; Phosphoprotein;
KW   Primary mitochondrial disease; Proteomics identification;
KW   Reference proteome; Ribosome biogenesis; Secreted; Transcription;
KW   Transcription regulation; Transit peptide.
FT   TRANSIT         1..73
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000269|PubMed:1830244,
FT                   ECO:0000269|PubMed:8662673, ECO:0007744|PubMed:25944712"
FT   CHAIN           74..282
FT                   /note="Complement component 1 Q subcomponent-binding
FT                   protein, mitochondrial"
FT                   /id="PRO_0000018590"
FT   REGION          76..93
FT                   /note="C1q binding"
FT   REGION          138..164
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          168..213
FT                   /note="Interaction with MAVS"
FT                   /evidence="ECO:0000269|PubMed:19164550"
FT   MOD_RES         87
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         91
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         188
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:17693683,
FT                   ECO:0007744|PubMed:19690332"
FT   MOD_RES         201
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         205
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         214
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   VARIANT         186
FT                   /note="C -> S (in COXPD33; uncertain significance;
FT                   dbSNP:rs748497469)"
FT                   /evidence="ECO:0000269|PubMed:28942965"
FT                   /id="VAR_080391"
FT   VARIANT         188
FT                   /note="Missing (in COXPD33; uncertain significance;
FT                   dbSNP:rs755568057)"
FT                   /evidence="ECO:0000269|PubMed:28942965"
FT                   /id="VAR_080392"
FT   VARIANT         204
FT                   /note="F -> L (in COXPD33; uncertain significance;
FT                   dbSNP:rs767427194)"
FT                   /evidence="ECO:0000269|PubMed:28942965"
FT                   /id="VAR_080393"
FT   VARIANT         247
FT                   /note="G -> W (in COXPD33; dbSNP:rs1394499137)"
FT                   /evidence="ECO:0000269|PubMed:28942965"
FT                   /id="VAR_080394"
FT   VARIANT         275
FT                   /note="L -> F (in COXPD33; uncertain significance;
FT                   dbSNP:rs1555532484)"
FT                   /evidence="ECO:0000269|PubMed:28942965"
FT                   /id="VAR_080395"
FT   VARIANT         275
FT                   /note="L -> P (in COXPD33; dbSNP:rs1555532483)"
FT                   /evidence="ECO:0000269|PubMed:28942965"
FT                   /id="VAR_080396"
FT   MUTAGEN         107
FT                   /note="G->D: Impairs HIVRNA splicing in mouse cells."
FT                   /evidence="ECO:0000269|PubMed:12833064"
FT   HELIX           77..95
FT                   /evidence="ECO:0007829|PDB:7TE3"
FT   TURN            106..108
FT                   /evidence="ECO:0007829|PDB:7TE3"
FT   STRAND          110..114
FT                   /evidence="ECO:0007829|PDB:7TE3"
FT   STRAND          117..123
FT                   /evidence="ECO:0007829|PDB:7TE3"
FT   STRAND          125..134
FT                   /evidence="ECO:0007829|PDB:7TE3"
FT   STRAND          167..174
FT                   /evidence="ECO:0007829|PDB:7TE3"
FT   HELIX           175..177
FT                   /evidence="ECO:0007829|PDB:1P32"
FT   STRAND          180..187
FT                   /evidence="ECO:0007829|PDB:7TE3"
FT   STRAND          199..201
FT                   /evidence="ECO:0007829|PDB:6SZW"
FT   STRAND          206..213
FT                   /evidence="ECO:0007829|PDB:7TE3"
FT   STRAND          225..227
FT                   /evidence="ECO:0007829|PDB:7TE3"
FT   HELIX           228..230
FT                   /evidence="ECO:0007829|PDB:3RPX"
FT   HELIX           233..245
FT                   /evidence="ECO:0007829|PDB:7TE3"
FT   HELIX           250..280
FT                   /evidence="ECO:0007829|PDB:7TE3"
SQ   SEQUENCE   282 AA;  31362 MW;  2F747FA73BB1314B CRC64;
     MLPLLRCVPR VLGSSVAGLR AAAPASPFRQ LLQPAPRLCT RPFGLLSVRA GSERRPGLLR
     PRGPCACGCG CGSLHTDGDK AFVDFLSDEI KEERKIQKHK TLPKMSGGWE LELNGTEAKL
     VRKVAGEKIT VTFNINNSIP PTFDGEEEPS QGQKVEEQEP ELTSTPNFVV EVIKNDDGKK
     ALVLDCHYPE DEVGQEDEAE SDIFSIREVS FQSTGESEWK DTNYTLNTDS LDWALYDHLM
     DFLADRGVDN TFADELVELS TALEHQEYIT FLEDLKSFVK SQ
//
